Desonate Gel Approved
How will this new porduct effect sales? Who will call on Peds? Much better than the recently approved Connetics Verdeso (burns, stings, causes skin atrophy). They even got the Deso prefix for the name "Desonate" and Connetics couldn't; ended up with Verdeso instead of Desilux. What a bunch of lucky losers at Connetics (bought out by Stefiel).
CARLSBAD, Calif., Oct. 23 /PRNewswire/ -- SkinMedica, Inc., a specialty pharmaceutical company focused on developing, acquiring and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Desonate (desonide gel) 0.05% for treatment of mild to moderate atopic dermatitis. Desonate is a low potency topical steroid formulated in a proprietary water- based Hydrogel vehicle developed and patented by Dow Pharmaceutical Sciences, Inc. The patented formula is free from alcohol, fragrance or surfactants which can be irritating or drying to the skin of atopic dermatitis patients. Desonate was developed in a collaborative effort between SkinMedica and Dow Pharmaceutical Sciences, Inc. and will be available to physicians in first quarter of 2007.
"The relationship with Dow Pharmaceutical Sciences enables us to expand our pipeline of dermatology products and build a robust franchise in the $1 billion topical steroid market," said Rex Bright, President and CEO of SkinMedica. "The launch of Desonate represents a significant addition to our portfolio of prescription and cosmeceutical dermatology products." "We are pleased to have partnered with SkinMedica in the development and approval of this important product utilizing our patented Hydrogel technology," said Bhaskar Chaudhuri, President and CEO of Dow Pharmaceutical Sciences.